BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21791608)

  • 1. Checkpoint kinase 1 prevents cell cycle exit linked to terminal cell differentiation.
    Ullah Z; de Renty C; DePamphilis ML
    Mol Cell Biol; 2011 Oct; 31(19):4129-43. PubMed ID: 21791608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of trophoblast stem cells into giant cells is triggered by p57/Kip2 inhibition of CDK1 activity.
    Ullah Z; Kohn MJ; Yagi R; Vassilev LT; DePamphilis ML
    Genes Dev; 2008 Nov; 22(21):3024-36. PubMed ID: 18981479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic localization of p21 protects trophoblast giant cells from DNA damage induced apoptosis.
    de Renty C; DePamphilis ML; Ullah Z
    PLoS One; 2014; 9(5):e97434. PubMed ID: 24848107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dual roles of geminin during trophoblast proliferation and differentiation.
    de Renty C; Kaneko KJ; DePamphilis ML
    Dev Biol; 2014 Mar; 387(1):49-63. PubMed ID: 24412371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.
    Lu Z; Hunter T
    Cell Cycle; 2010 Jun; 9(12):2342-52. PubMed ID: 20519948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of mice without Cip/Kip CDK inhibitors.
    Tateishi Y; Matsumoto A; Kanie T; Hara E; Nakayama K; Nakayama KI
    Biochem Biophys Res Commun; 2012 Oct; 427(2):285-92. PubMed ID: 23000166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular Response upon Stress: p57 Contribution to the Final Outcome.
    Rossi MN; Antonangeli F
    Mediators Inflamm; 2015; 2015():259325. PubMed ID: 26491224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodic expression of the cyclin-dependent kinase inhibitor p57(Kip2) in trophoblast giant cells defines a G2-like gap phase of the endocycle.
    Hattori N; Davies TC; Anson-Cartwright L; Cross JC
    Mol Biol Cell; 2000 Mar; 11(3):1037-45. PubMed ID: 10712518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Location of cell cycle regulators cyclin B1, cyclin A, PCNA, Ki67 and cell cycle inhibitors p21, p27 and p57 in human first trimester placenta and deciduas.
    Korgun ET; Celik-Ozenci C; Acar N; Cayli S; Desoye G; Demir R
    Histochem Cell Biol; 2006 Jun; 125(6):615-24. PubMed ID: 16491347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.
    Tury A; Mairet-Coello G; DiCicco-Bloom E
    Cereb Cortex; 2011 Aug; 21(8):1840-56. PubMed ID: 21245411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle reentry of differentiated cells.
    Bilodeau S; Roussel-Gervais A; Drouin J
    Mol Cell Biol; 2009 Apr; 29(7):1895-908. PubMed ID: 19139274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDK inhibitors selectively diminish cell cycle controlled activation of the histone H4 gene promoter by p220NPAT and HiNF-P.
    Mitra P; Ghule PN; van der Deen M; Medina R; Xie RL; Holmes WF; Ye X; Nakayama KI; Harper JW; Stein JL; Stein GS; van Wijnen AJ
    J Cell Physiol; 2009 May; 219(2):438-48. PubMed ID: 19170105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK inhibitors, p21(Cip1) and p27(Kip1), participate in cell cycle exit of mammalian cardiomyocytes.
    Tane S; Ikenishi A; Okayama H; Iwamoto N; Nakayama KI; Takeuchi T
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1105-9. PubMed ID: 24380855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.
    Lee MH; Reynisdóttir I; Massagué J
    Genes Dev; 1995 Mar; 9(6):639-49. PubMed ID: 7729683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of cell cycle arrest and terminal differentiation in a maximally proliferative human epithelial tissue: Lessons from the human hair follicle matrix.
    Purba TS; Brunken L; Peake M; Shahmalak A; Chaves A; Poblet E; Ceballos L; Gandarillas A; Paus R
    Eur J Cell Biol; 2017 Sep; 96(6):632-641. PubMed ID: 28413121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
    Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ
    Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New cell or new cycle?
    Ganier O; Mechali M
    Genes Dev; 2008 Nov; 22(21):2908-13. PubMed ID: 18981469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: Chk1 directs senescence and mitotic catastrophe in recovery from G₂ checkpoint arrest.
    Poehlmann A; Habold C; Walluscheck D; Reissig K; Bajbouj K; Ullrich O; Hartig R; Gali-Muhtasib H; Diestel A; Roessner A; Schneider-Stock R
    J Cell Mol Med; 2011 Jul; 15(7):1528-41. PubMed ID: 20716119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of p57(KIP2) during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation.
    Figliola R; Busanello A; Vaccarello G; Maione R
    J Mol Biol; 2008 Jul; 380(2):265-77. PubMed ID: 18513743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.